U.S. flag

An official website of the United States government

GRCh37/hg19 Xp21.1-11.22(chrX:36355238-54106257)x1 AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 19, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003483920.1

Allele description [Variation Report for GRCh37/hg19 Xp21.1-11.22(chrX:36355238-54106257)x1]

GRCh37/hg19 Xp21.1-11.22(chrX:36355238-54106257)x1

Genes:
Variant type:
copy number loss
Cytogenetic location:
Xp21.1-11.22
Genomic location:
ChrX: 36355238 - 54106257 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 Xp21.1-11.22(chrX:36355238-54106257)x1
HGVS:

    Condition(s)

    Synonyms:
    none provided
    Identifiers:
    MedGen: C3661900

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...

    Assertion and evidence details

    Submission AccessionSubmitterReview Status
    (Assertion method)
    Clinical Significance
    (Last evaluated)
    OriginMethodCitations
    SCV004230340Quest Diagnostics Nichols Institute San Juan Capistrano
    criteria provided, single submitter

    (ACMG/ClinGen CNV Guidelines, 2019)
    Pathogenic
    (Sep 19, 2022)
    unknownclinical testing

    PubMed (1)
    [See all records that cite this PMID]

    Summary from all submissions

    EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
    not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

    Citations

    PubMed

    Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).

    Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, Pineda-Alvarez D, Aradhya S, Martin CL.

    Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6. Erratum in: Genet Med. 2021 Nov;23(11):2230. doi: 10.1038/s41436-021-01150-9.

    PubMed [citation]
    PMID:
    31690835
    PMCID:
    PMC7313390

    Details of each submission

    From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV004230340.1

    #EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
    1not providednot providednot providednot providedclinical testing PubMed (1)

    Description

    The copy number loss of Xp21.1p11.22 involves numerous protein-coding genes. Haploinsufficiency of DDX3X is associated with autosomal dominant syndromic X-linked intellectual disability of the Snijders Blok type (OMIM 300958, Rehm 2015 (HGNC:2745)). Furthermore, deletions of Xp11.4p11.3 have been identified in female patients with a variety of phenotypes (Catino 2022, Hinds 2018). There are no similar copy number losses of this region in the general populations of the Database of Genomic Variants. Thus, based on current medical literature and gene content, this copy number variant (CNV) is classified as pathogenic. References: Catino et al., Am J Med Genet A. 2022 Jun;188(6):1836-1847. PMID: 35238482 Hinds et al., Ophthalmic Genet. 2018 Jun;39(3):396-398. PMID: 29617172 Rehm et al., N Engl J Med. 2015 Jun 4;372(23):2235-42. PMID: 26014595 (HGNC:2745)

    #SampleMethodObservation
    OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
    1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

    Last Updated: Feb 4, 2024